Skip to main content
TipRanks
Go Ultimate75% OFF

Sankesh Abbhi Insider Profile

4 Followers

Sankesh Abbhi, Director at Brainstorm Cell Therapeutics, holds 2.18M shares in Brainstorm Cell Therapeutics (Ticker: BCLI).

Sankesh Abbhi's Trading History

BCLI
Brainstorm Cell Therapeutics
Dec 10, 2021DirectorUninformative Buy―$2.07M
BCLI
Insider Shares: 2.18M (6.00%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Dec 10, 2021Uninformative Buy$0.006,666$0.00―
Jul 16, 2020Informative Buy$607.66K46,779$12.99―
Apr 07, 2020Uninformative Buy$0.004,657$0.00―

You May Also Like

Sankesh Abbhi insider profile FAQ

What stocks does Sankesh Abbhi hold?
Sankesh Abbhi holds: BCLI stocks.
What is Sankesh Abbhi's role in Brainstorm Cell Therapeutics?
Sankesh Abbhi's role in Brainstorm Cell Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.